The 5-year onset and regression of diabetic retinopathy in Chinese type 2 diabetes patients

PLoS ONE

Volumn 9, Issue 11, 2014, Pages

  Jin, Peiyao ^a   Peng, Jinjuan ^a   Zou, Haidong ^a,b   Wang, Weiwei ^c   Fu, Jiong ^c   Shen, Binjie ^c   Bai, Xuelin ^c   Xu, Xun ^a   Zhang, Xi ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b Shanghai Eye Disease Prevention and Treatment Center   (China)

^c Beixinjing Community Health Service Center   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BEVACIZUMAB; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GLUCOSE; HEMOGLOBIN A1C; MEGLITINIDE; METFORMIN; SULFONYLUREA DERIVATIVE; TRIACYLGLYCEROL; GLYCOSYLATED HEMOGLOBIN; INSULIN;

ADULT; AGED; ARTICLE; CAMERA; CHINA; CHINESE; CONTROLLED STUDY; DIABETIC RETINOPATHY; EYE EXAMINATION; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; HYPERTENSION; ION EXCHANGE CHROMATOGRAPHY; LASER COAGULATION; MAJOR CLINICAL STUDY; MALE; MICROCIRCULATION; MIDDLE AGED; NEPHELOMETRY; NON INSULIN DEPENDENT DIABETES MELLITUS; ONSET AGE; PROSPECTIVE STUDY; REMISSION; RETINOGRAPHY; RISK ASSESSMENT; RISK FACTOR; SLIT LAMP; TRIACYLGLYCEROL BLOOD LEVEL; VERY ELDERLY; VISUAL ACUITY; YOUNG ADULT; COMPLICATION; FOLLOW UP; INCIDENCE; METABOLISM; PATHOPHYSIOLOGY; PROGNOSIS;

AGE OF ONSET; AGED; AGED, 80 AND OVER; CHINA; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERGLYCEMIA; HYPERTENSION; INCIDENCE; INSULIN; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 84913589661     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0113359     Document Type: Article

References (49)

1. Klein K, Eden B (2007) Overview of epidemiologic studies of diabetic retinopathy. Ophthalmic epidemiology 14: 179-183.
2. Younis N, Broadbent DM, Vora JP, Harding SP, Liverpool Diabetic Eye S (2003) Incidence of sight-threatening retinopathy in patients with type 2 diabetes in the Liverpool Diabetic Eye Study: A cohort study. Lancet 361: 195-200.
3. Yang W, Lu J, Weng J, Jia W, Ji L, et al. (2010) Prevalence of diabetes among men and women in China. New England Journal of Medicine 362: 1090-1101.
4. Klein R, Klein BE, Moss SE, Davis MD, DeMets DL (1989) The Wisconsin Epidemiologic Study of Diabetic Retinopathy: X. Four-Year Incidence and Progression of Diabetic Retinopathy When Age at Diagnosis Is 30 Years or More. Archives of ophthalmology 107: 244.
5. Zhang L, Krzentowski G, Albert A, Lefebvre PJ (2001) Risk of developing retinopathy in Diabetes Control and Complications Trial type 1 diabetic patients with good or poor metabolic control. Diabetes Care 24: 1275-1279.
6. Scanlon PH, Aldington SJ, Stratton IM (2013) Epidemiological issues in diabetic retinopathy. Middle East African journal of ophthalmology 20: 293.
7. Stratton IM, Kohner EM, Aldington SJ, Turner RC, Holman RR, et al. (2001) UKPDS 50: risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis. Diabetologia 44: 156-163.
8. Perol J, Balkau B, Guillausseau P-J, Massin P (2012) A study of the 3-year incidence of diabetic retinopathy in a French diabetic population seen at Lariboisière Hospital, Paris. Diabetes & metabolism 38: 225-229.
9. Cikamatana L, Mitchell P, Rochtchina E, Foran S, Wang J (2007) Five-year incidence and progression of diabetic retinopathy in a defined older population: the Blue Mountains Eye Study. Eye 21: 465-471.
10. Tam VH, Lam EP, Chu BC, Tse KK, Fung LM (2009) Incidence and progression of diabetic retinopathy in Hong Kong Chinese with type 2 diabetes mellitus. J Diabetes Complications 23: 185-193.
11. Wang N, Xu X, Zou H, Zhu J, Wang W, et al. (2007) The status of diabetic retinopathy and diabetic macular edema in patients with type 2 diabetes: A survey from Beixinjing District of Shanghai city in China. Ophthalmologica 222: 32-36.
12. Arevalo JF, Wu L, Sanchez JG, Maia M, Saravia MJ, et al. (2009) Intravitreal bevacizumab (Avastin) for proliferative diabetic retinopathy: 6-months followup. Eye (Lond) 23: 117-123.
13. Yang CS, Hung KC, Huang YM, Hsu WM (2013) Intravitreal bevacizumab (Avastin) and panretinal photocoagulation in the treatment of high-risk proliferative diabetic retinopathy. J Ocul Pharmacol Ther 29: 550-555.
14. Mirshahi A, Roohipoor R, Lashay A, Mohammadi SF, Abdoallahi A, et al. (2008) Bevacizumab-augmented retinal laser photocoagulation in proliferative diabetic retinopathy: A randomized double-masked clinical trial. Eur J Ophthalmol 18: 263-269.
15. Zavrelova H, Hoekstra T, Alssema M, Welschen LM, Nijpels G, et al. (2011) Progression and regression: distinct developmental patterns of diabetic retinopathy in patients with type 2 diabetes treated in the diabetes care system west-friesland, the Netherlands. Diabetes Care 34: 867-872.
16. Gerritzen F (1973) The course of diabetic retinopathy: A longitudinal study. Diabetes 22: 122-128.
17. Han JR, Ju WK, Park IW (2004) Spontaneous regression of neovascularization at the disc in diabetic retinopathy. Korean Journal of Ophthalmology 18: 41-46.
18. White M, Kohner E, Pickup J, Keen H (1981) Reversal of diabetic retinopathy by continuous subcutaneous insulin infusion: A case report. British Journal of Ophthalmology 65: 307-311.
19. Sjolie AK, Klein R, Porta M, Orchard T, Fuller J, et al. (2008) Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): A randomised placebo-controlled trial. Lancet 372: 1385- 1393.
20. Aiello LP, Edwards AR, Beck RW, Bressler NM, Davis MD, et al. (2010) Factors associated with improvement and worsening of visual acuity 2 years after focal/grid photocoagulation for diabetic macular edema. Ophthalmology 117: 946- 953.
21. Theodossiadis GP, Boudouri A, Georgopoulos G, Koutsandrea C (1990) Central visual field changes after panretinal photocoagulation in proliferative diabetic retinopathy. Ophthalmologica 201: 71-78.
22. López F, Rodríguez M, Marticorena J, Gómez-Ulla F (2007) Diabetic Retinopathy Treatment. European Ophthalmic Review: 68-70.
23. Consultation W (1999) Definition, diagnosis and classification of diabetes mellitus and its complications: Part.
24. Wu Y (2006) Overweight and obesity in China: the once lean giant has a weight problem that is increasing rapidly. BMJ: British Medical Journal 333: 362.
25. Peng J, Zou H, Wang W, Fu J, Shen B, et al. (2011) Implementation and firstyear screening results of an ocular telehealth system for diabetic retinopathy in China. BMC health services research 11: 250.
26. Gibbins R, Owens D, Allen J, Eastman L (1998) Practical application of the European Field Guide in screening for diabetic retinopathy by using ophthalmoscopy and 35 mm retinal slides. Diabetologia 41: 59-64.
27. Wilkinson CP, Ferris FL 3rd, Klein RE, Lee PP, Agardh CD, et al. (2003) Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology 110: 1677-1682.
28. Varma R, Choudhury F, Klein R, Chung J, Torres M, et al. (2010) Four-year incidence and progression of diabetic retinopathy and macular edema: the Los Angeles Latino Eye Study. Am J Ophthalmol 149: 752-761 e751-753.
29. Leske MC, Wu S-Y, Hennis A, Nemesure B, Hyman L, et al. (2003) Incidence of diabetic retinopathy in the Barbados Eye Studies. Ophthalmology 110: 941- 947.
30. Manaviat M, Rashidi M, Afkhami-Ardekani M (2008) Four years incidence of diabetic retinopathy and effective factors on its progression in type II diabetes. European journal of ophthalmology 18: 572-577.
31. Kawasaki R, Tanaka S, Yamamoto T, Sone H, Ohashi Y, et al. (2011) Incidence and progression of diabetic retinopathy in Japanese adults with type 2 diabetes: 8 year follow-up study of the Japan Diabetes Complications Study (JDCS). Diabetologia 54: 2288-2294.
32. Tapp RJ, Zimmet PZ, Harper CA, McCarty DJ, Chitson P, et al. (2006) Six year incidence and progression of diabetic retinopathy: results from the Mauritius diabetes complication study. Diabetes research and clinical practice 73: 298- 303.
33. Grant MB, Afzal A, Spoerri P, Pan H, Shaw LC, et al. (2004) The role of growth factors in the pathogenesis of diabetic retinopathy. Expert opinion on investigational drugs 13: 1275-1293.
34. Younis N, Broadbent DM, Vora JP, Harding SP (2003) Incidence of sightthreatening retinopathy in patients with type 2 diabetes in the Liverpool Diabetic Eye Study: A cohort study. The Lancet 361: 195-200.
35. Bao Y, Ma X, Li H, Zhou M, Hu C, et al. (2010) Glycated haemoglobin A1c for diagnosing diabetes in Chinese population: cross sectional epidemiological survey. BMJ 340.
36. Raymond NT, Varadhan L, Reynold DR, Bush K, Sankaranarayanan S, et al. (2009) Higher prevalence of retinopathy in diabetic patients of South Asian ethnicity compared with White Europeans in the Community A cross-sectional study. Diabetes care 32: 410-415.
37. Ruggenenti P, Iliev I, Filipponi M, Tadini S, Perna A, et al. (2010) Effect of trandolapril on regression of retinopathy in hypertensive patients with type 2 diabetes: A prespecified analysis of the benedict trial. Journal of ophthalmology 2010.
38. Zheng Z, Chen H, Ke G, Fan Y, Zou H, et al. (2009) Protective Effect of Perindopril on Diabetic Retinopathy Is Associated With Decreased Vascular Endothelial Growth Factor-to-Pigment Epithelium-Derived Factor Ratio Involvement of a Mitochondria-Reactive Oxygen Species Pathway. Diabetes 58: 954-964.
39. Steigerwalt R, Belcaro G, Cesarone MR, Di Renzo A, Grossi MG, et al. (2009) Pycnogenol improves microcirculation, retinal edema, and visual acuity in early diabetic retinopathy. J Ocul Pharmacol Ther 25: 537-540.
40. Schonlau F, Rohdewald P (2001) Pycnogenol for diabetic retinopathy. A review. Int Ophthalmol 24: 161-171.
41. Sjolie AK, Klein R, Porta M, Orchard T, Fuller J, et al. (2011) Retinal microaneurysm count predicts progression and regression of diabetic retinopathy. Post-hoc results from the DIRECT Programme. Diabet Med 28: 345-351.
42. Hellstedt T, Immonen I (1996) Disappearance and formation rates of microaneurysms in early diabetic retinopathy. British journal of ophthalmology 80: 135-139.
43. Gordon B, Chang S, Kavanagh M, Berrocal M, Yannuzzi L, et al. (1991) The effects of lipid lowering on diabetic retinopathy. Am J Ophthalmol 112: 385- 391.
44. Kameda Y, Kumakawa M, Endo N, Iwamoto Y, Kitano S (2010) Association of systemic health and functional outcomes with changes in hard exudates associated with clinically significant macular oedema over the natural course of the disease. British Journal of Ophthalmology 94: 725-729.
45. Higashi S, Clermont AC, Dhir V, Bursell S-E (1998) Reversibility of retinal flow abnormalities is disease-duration dependent in diabetic rats. Diabetes 47: 653- 659.
46. Engerman RL (1989) Pathogenesis of diabetic retinopathy. Diabetes 38: 1203- 1206.
47. Roy S, Sala R, Cagliero E, Lorenzi M (1990) Overexpression of fibronectin induced by diabetes or high glucose: phenomenon with a memory. Proc Natl Acad Sci U S A 87: 404-408.
48. White NH, Sun W, Cleary PA, Danis RP, Davis MD, et al. (2008) Prolonged effect of intensive therapy on the risk of retinopathy complications in patients with type 1 diabetes mellitus: 10 years after the Diabetes Control and Complications Trial. Arch Ophthalmol 126: 1707-1715.
49. Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA (2008) 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 359: 1577-1589.